http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2108185-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-00 |
| filingDate | 1971-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1972-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2108185-A1 |
| titleOfInvention | N-(3-aminoalkyl-2-oxo-2h-1-benzopyran-7-yl) ureas - as coronary vasodilators |
| abstract | N-(3-aminoalkyl-2-oxo-2H-1-Benzopyran-7-yl) ureas- as coronary vasodilators. Cpds (I) and their salts. (where R1, R2, R5 and R6 are H, 1-4C alkyl opt.-OH substd. cycloalkyl, aralkyl or aryl opt substd. by one or two halogen, alkyl, alkoxy, OH or CF3, or NR1R2 and NR5R6 are 3-7 membered heterocyclic rings opt. contg. 1-3-hetero atoms and opt substd. by aryl alkyl opt OH substd. halogen or CF3 R4 is H or 1-3C alkyl, R7 is H, aryl or 1-3C alkyl, Z is halogen, 1-3C -alkyl or alkoxy, n is 0, 1 or 2, and U is 2-5C alkylene opt. OH substd) are prepd. by a number of methods involving the formation of the amino gps. NR1R2 and NR5R6 or the formation of the urea residue. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7115750-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4452811-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0121577-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9408985-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0121577-A3 |
| priorityDate | 1971-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.